Vaxcyte, Inc. (PCVX) SEC Filings — 2025
10 SEC filings for Vaxcyte, Inc. (PCVX) in 2025.
Filings
- Vaxcyte, Inc. Files 8-K: Officer/Director Changes & Financials — 8-K · Dec 19, 2025
- Vaxcyte's R&D Soars, Net Loss Widens to $520M Amid Vaccine Push — 10-Q · Nov 4, 2025
- Vaxcyte, Inc. Enters Material Definitive Agreement — 8-K · Sep 30, 2025
- Vaxcyte's Q2 Losses Widen Amid Accelerated R&D for Key Vaccines — 10-Q · Aug 6, 2025
- Vaxcyte, Inc. Files 8-K on Shareholder Vote Matters — 8-K · Jun 17, 2025
- Vaxcyte, Inc. Files Q1 2025 10-Q Report — 10-Q · May 7, 2025
- Vaxcyte Announces Board Changes and Executive Compensation Updates — 8-K · May 1, 2025
- Vaxcyte DEF 14A: Executive Pay & Governance Details — DEF 14A · Apr 28, 2025
- Vaxcyte, Inc. 8-K Filing — 8-K · Mar 31, 2025
- Vaxcyte, Inc. 10-K Filing — 10-K · Feb 25, 2025